or Try an Advanced Search...

    Treatment Of Diabetes Stocks List

    Symbol Grade Name % Change
    BMY B Bristol-Myers Squibb Company 2.24
    BDX B Becton, Dickinson and Company 0.24
    PODD C Insulet Corporation 0.78
    ASND C Ascendis Pharma A/S -1.82
    ORMP F Oramed Pharmaceuticals Inc. -1.64
    IONS F Ionis Pharmaceuticals, Inc. -2.47
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Medical Devices Medical Instruments & Supplies
    Related Stock Lists: Diabetes Insulin Medicine S&P 500 Biotechnology Cancer Dystrophy Endocrine System Hepatitis B Hepatitis B Virus Hepatitis C Hepatitis C Virus Hepatitis C Virus Infection Hypertension Lipodystrophy Peptide Hormones Pharmaceutical Acromegaly Alcohol Alport Syndrome

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Diabetes stocks.

    Symbol Grade Name Weight
    MEDI C Harbor Health Care ETF 15.05
    WBIG B WBI Large Cap Tactical Yield Shares 8.38
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 6.94
    IHI C iShares U.S. Medical Devices ETF 6.46
    RDIV A RevenueShares Ultra Dividend Fund 5.39
    View all Treatment Of Diabetes ETFs...
    Compare ETFs
    Compare FTXH to RDIV Compare WBIG to FTXH Compare WBIG to RDIV

        Treatment Of Diabetes Stocks Recent News

        Date Stock Title
        Oct 1 BDX BDX upped to buy by Citi, TNDM put on Negative Catalyst Watch
        Oct 1 BMY PRME Stock Rises 11.8% on Collaboration With Bristol Myers
        Oct 1 BMY A schizophrenia win for BMS’ Cobenfy, but challenges lie ahead
        Oct 1 ASND Ascendis Pharma submits sBLA for growth hormone deficiency therapy
        Oct 1 BMY BMS and Prime ink potential $3.5bn deal to develop T cell therapies
        Oct 1 IONS Ionis gets U.S. FDA fast track designation for its Alexander disease treatment
        Oct 1 BMY Read This Before Considering Bristol-Myers Squibb Company (NYSE:BMY) For Its Upcoming US$0.60 Dividend
        Oct 1 PODD Fidelity Growth Strategies Fund Trimmed Insulet Corporation (PODD) to Manage the Position Size
        Oct 1 IONS Zilganersen granted U.S. FDA Fast Track designation for people living with Alexander disease
        Oct 1 ASND High Growth Tech Stocks To Watch In October 2024
        Oct 1 BMY 5 FDA decisions to watch in the fourth quarter
        Oct 1 BMY Bristol-Myers Squibb Company (BMY) is Driving Growth Through Strategic Acquisitions
        Sep 30 BMY Bristol Myers gets $6.4B Celgene CVR case dismissed: report
        Sep 30 BMY Sector Update: Health Care Stocks Advance Late Afternoon
        Sep 30 BMY US Judge Dismisses $6.4 Billion Suit Against Bristol Myers Over Delay in Drug Approvals
        Sep 30 BMY Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug
        Sep 30 BMY Prime Medicine stock rallies 15% on Bristol Myers deal, drug updates
        Sep 30 BMY Bristol, Prime Medicine in deal to develop T-cell therapies
        Sep 30 BMY Company News for Sep 30, 2024
        Sep 30 BMY Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline
        Related Industries: Biotechnology Drug Manufacturers - Major Medical Devices Medical Instruments & Supplies
        Related Stock Lists: Diabetes Insulin Medicine S&P 500 Biotechnology Cancer Dystrophy Endocrine System Hepatitis B Hepatitis B Virus Hepatitis C Hepatitis C Virus Hepatitis C Virus Infection Hypertension Lipodystrophy Peptide Hormones Pharmaceutical Acromegaly Alcohol Alport Syndrome
        Treatment Of Diabetes

        Treatment of diabetes focuses on keeping blood sugar levels within a normal range. This can be achieved through lifestyle changes, such as eating a healthy diet, exercising regularly, and maintaining a healthy weight. Medications may also be necessary to help control blood sugar levels. In some cases, insulin injections may be required.

        Browse All Tags